This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs

No Significant Event

Official Name : CAPT Denise Hinton, Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date : 06/26/2017 - 06/26/2017
Location : Washington, D.C.
Subject : Lupus Foundation of America: What Do You Believe are the Barriers to Lupus Research/Drug Development?
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 06/29/2017 - 06/29/2017
Location : Silver Spring, MD
Subject : Regulation of Hearing Aids
FDA Participant/Group : JONETTE FOY; VASANT DASIKA; IAN OSTERMILLER; SRINIVAS NANDKUMAR; SHU-CHEN PENG; ERIC MANN;
Non FDA Participant/Group : Marc Lundeberg, Tom Tedeschi, Heinz Ruch, Raimondo Fusco, Nate Brown (Amplifon Americas);

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

Event Date : 06/28/2017 - 06/28/2017
Location : Washington, D.C.
Subject : Pew Charitable Trusts Quarterly Meeting: Items of Mutual Interest
FDA Participant/Group : ERIK METTLER; STEVEN VAUGHN; LAURA BRADBARD; MICHAEL MURPHY; WILLIAM FLYNN; DANIEL MCCHESNEY; NADINE STEINBERG;
Non FDA Participant/Group : Karin Hoelzer, Kathy Talkington, Kyle Kinner, Nora Wong (Pew Charitable Trusts);

Event Date : 06/30/2017 - 06/30/2017
Location : Silver Spring, MD
Subject : Phibro Animal Health: Items of Mutual Interest
FDA Participant/Group : WILLIAM FLYNN;
Non FDA Participant/Group : Denise Esposito (Covington & Burling, LLP.); Judy Weinstein (Phibro Animal Health);

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date : 06/25/2017 - 06/28/2017
Location : Denver, CO
Subject : Teratology Society Annual Meeting: Changes in Serum Lipid Profiles in Neonatal Monkeys Associated with Sevoflurane-Induced Neurotoxicity
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel

No Significant Event